West Pharmaceutical Services
WST
#1237
Rank
S$23.31 B
Marketcap
S$323.43
Share price
0.57%
Change (1 day)
7.69%
Change (1 year)
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company produces rubber components for packaging injectable drugs and for providing a sterile environment.

Operating Margin for West Pharmaceutical Services (WST)

Operating Margin as of April 2026 (TTM): 19.54%

According to West Pharmaceutical Services's latest financial reports and stock price the company's current Operating Margin is 19.54%. At the end of 2025 the company had an Operating Margin of 19.55%.

Operating Margin history for West Pharmaceutical Services from 2001 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202519.55%-3.41%
202420.24%-14.48%
202323.66%0.47%
202223.55%-10.95%
202126.45%41.49%
202018.69%17.86%
201915.86%13.16%
201814.02%0.77%
201713.91%10.58%
201612.58%51.64%
20158.29%-30.24%
201411.89%10.6%
201310.75%25.35%
20128.58%10.3%
20117.77%15.29%
20106.74%-14.33%
20097.87%-24.44%
200810.42%23%
20078.47%-8.46%
20069.25%5.44%
20058.78%12.09%
20047.83%-41.33%
200313.34%71.06%
20027.80%9.68%
20017.11%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
Johnson & Johnson
JNJ
34.58% 76.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
16.78%-14.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Baxter
BAX
-4.49%-122.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
8.98%-54.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
17.97%-8.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teleflex
TFX
1.23%-93.71%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
0.19%-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
31.38% 60.61%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.